Active Biotech AB operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Active Biotech AB with three other
companies in this sector in Sweden:
Sprint Bioscience AB
sales of 17.94 million Swedish Kronor [US$1.85 million]
Xbrane Biopharma Ab
(20.49 million Swedish Kronor [US$2.11 million]
of which 380%
was Biosimilars), and
(23.86 million Swedish Kronor [US$2.46 million]
of which 100%
Active Biotech AB reported sales of SEK 20.05 million (US$2.07 million)
December of 2018.
decrease of 1.0%
versus 2017, when the company's sales were SEK 20.25 million.
Contributing to the drop in overall sales was the 59.7% decline
in Research Services, from SEK 2.74 million to SEK 1.11 million.
However, these declines were partially offset by the increase in sales of
Rental Revenues (up 6.8% to SEK 16.04 million)
Service Revenues (up 17.8% to SEK 2.90 million)